openPR Logo
Press release

Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031

04-19-2024 03:23 PM CET | Health & Medicine

Press release from: Orion Market Research

Topical Drug Delivery Market Will Exhibit an Impressive

The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance,

• In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel. This newly approved drug is for the topical treatment of actinic keratoses and now it is a reference listed drug product (RLD) Solaraze Topical Gel, 3%.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/topical-drug-delivery-market

• In July 2022, Arcutis Biotherapeutics, Inc. received approval by the US FDA for its New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% that is used in the treatment of plaque psoriasis, including intertriginous areas. This newly approved drug offers rapid clearance of psoriasis plaques and reduces itching, and it is set to be available by mid of August 2022.

• In August 2020, LEO Pharma A/S, an investigational topical pan-Janus kinase (JAK)-inhibitor, a delgocitinib cream, has been granted Fast Track designation by the US FDA for the treatment of adults with moderate-to-severe chronic hand eczema (CHE).

• In June 2020, TDupixent (dupilumab) used for treating moderate-to-severe atopic dermatitis in adults has been approved by the National Medical Products Administration (NMPA) in China. It stated Dupixent as an overseas medicine and approval was based on positive data from the global LIBERTY AD clinical trial program and is medicine considered urgently needed in clinical practice.

Global Topical Drug Delivery Market Report Segment

By Product

• Semi-Solid Formulations
o Creams
o Ointments
o Lotions
o Gel
o Pastes
• Liquid Formulations
o Suspensions
o Solutions
• Solid Formulations
o Powders
o Suppositories
• Transdermal Products
o Transdermal Patches
o Transdermal Semi-Solids

By Route of Administration

• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

By Facility of Use

• Home Care Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

A full report of Topical Drug Delivery Market is available at: https://www.omrglobal.com/industry-reports/topical-drug-delivery-market

Topical Drug Delivery Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• 3M Co.
• Akorn Operating Co. LLC
• Bausch Health Companies Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• CMP Pharma, Inc.
• Cipla
• Crescita Therapeutics Inc.
• Galderma SA
• Hisamitsu Pharmaceutical Co., Inc.
• Ingenus Pharmaceuticals, LLC

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031 here

News-ID: 3470443 • Views:

More Releases from Orion Market Research

US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
US Geriatric Medicine Market Size, Trends, Latest Insights, Analysis and Forecas …
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period. The US has high per capita income; access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country. Moreover, a significant presence of key market players, such as Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urometer Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Urethral Dilators Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global urethral dilators market is anticipated to grow at a considerable CAGR of 4.9% during the forecast. The growing incidence of Healthcare-Acquired Infections (HAI) is Boosting the Global Urethral Dilators Market. These are infections that patients get while receiving treatment for medical or surgical conditions. These infections can be occurred in hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities. To
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
Transvaginal Endoscopy Market Will Exhibit an Impressive Expansion by 2024-2031
The global transvaginal endoscopy market is anticipated to grow at a significant CAGR of 7.3% during the forecast period. Some of the prominent factors driving the market growth during the forecast period include the rising incidence of infertility among the female rising incidence of infertility globally, coupled with the increasing use of minimally invasive surgery. The MIS procedures involves minminal use of surgical incisions, and with the advent of laproscopic

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug